Regenative Labs produces regenerative medicine products to address the root cause of a patient's conditions using Wharton’s Jelly innovations rather than masking the pain with other treatments. Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development. Formed by veteran industry professionals familiar with daily challenges of innovations in healthcare, the company provides effective, non-addictive, non-invasive options for patients. Regenative Labs as a laser-focused, expert product research and development team which follows FDA guidelines of minimal manipulation for homologous use. The company adheres to AATB and FDA guidelines.
Regenative Lab’s mission is to facilitate predictable patient outcomes by providing the highest quality human tissue allografts available. We demonstrate our commitment to quality by collecting data from patient outcomes and analyzing the data for statistical significance, ensuring physicians make the most informed decision for the health of their patients. With the goal of addressing the root cause, rather than masking the pain, Regenative Labs birth tissue allografts provide an effective, non-addictive, non-invasive option for patients in debilitating situations.
Our first-class, state-of-the-art production facility is located in Pensacola, Florida. We spared no expense when it came to the technology that we all insisted was necessary to produce the quality regenerative products we expect for our partners. Tours of the lab are available by appointment.
Regenative Labs products are manufactured in state-of-the-art ISO Class 7 cleanrooms. Our lab features Advanced Air Quality Systems, ISO Class 5 Biological Safety Cabinets, Ultra-Low -80C Freezer Systems, and Advanced Quality Control Systems. All equipment is calibrated and validated to ensure valid and consistent results are produced.